<DOC>
	<DOC>NCT00290550</DOC>
	<brief_summary>This is a study to evaluate the effectiveness of an investigational drug in patients with cancer of the lung.</brief_summary>
	<brief_title>A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Patients who are at least 18 years of age with cancer of the lung and who have had either no previous treatment or 1 previous treatment for advanced cancer of the lung. Certain other treatments may also be allowed (prior cytotoxic chemotherapy in the adjuvant setting) Patients who have had treatment with any investigational therapy within the past 30 days are not eligible. Patients who have had a disease or medical condition that is not controlled will not be eligible. Patients who are pregnant or breastfeeding are not eligible.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Advanced Non-Small Cell Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
</DOC>